Women receiving biological therapies for psoriasis reported lower satisfaction and more side effects compared with men, according to study data published in the Journal of the European Academy of Dermatology and Venereology.

Investigators abstracted data from the prospective, longitudinal Continuous Assessment of Psoriasis Treatment Use Registry with Biologics (BioCAPTURE registry). The BioCAPTURE registry collects daily practice data for patients with psoriasis from 16 centers in The Netherlands.